Pluristyx's iPSC platform provides therapeutic developers with a streamlined path from research to clinical application, offering high-quality, regulatory-compliant starting materials and advanced ...

In preclinical tumor models, IMANs enhanced effector cell recruitment, resulting in increased tumor cell death. Additionally, they synergised with CAR-T cells to enhance tumor clearance in models of ...

Ms. Penkus Corzo has vast experience as a biopharma executive, drug developer and independent board director with more than 30 years of global leadership spanning R&D, clinical trials, regulatory ...

Evotec AG ( ($EVO) ) has shared an announcement. On November 4, 2025, Evotec SE announced a significant agreement with Sandoz AG involving the ...

Discovery & Preclinical Development segment ("D&PD", (12.3)%) still sees soft demand;Just - Evotec Biologics ("JEB"; +11.3%) above-expectation; further accelerating growth on non-Sandoz / non-DOD ...

The lab-made 3D liver model serves as a human relevant platform for analyzing the progressive stages of the liver disease, ...

Human progenitors are programmed into ependymal cells in brain organoids via GEMC1 and MCIDAS expression. This strategy ...